UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
||
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Events. |
On June 21, 2023, Cerence Inc. (the “Company”) issued a press release announcing the Company’s proposed private offering of $190 million aggregate principal amount of convertible senior notes due 2028 (the “Offering”) pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
On June 22, 2023, the Company issued a press release announcing that it had priced the Offering. A copy of the press release is filed as Exhibit 99.2 hereto and is incorporated herein by reference.
(d) Exhibits
Item 9.01. | Financial Statements and Exhibits. |
Exhibit Number |
Description | |
99.1 | Press Release issued by Cerence Inc. on June 21, 2023 | |
99.2 | Press Release issued by Cerence Inc. on June 22, 2023 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Cautionary Note Regarding Forward Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. These statements include, but are not limited to, statements concerning the proposed Offering. Forward looking statements include all statements that are not historical facts. In some cases, forward-looking statements can be identified by terms such as “potential,” “will,” or similar expressions and the negatives of those words. Forward-looking statements involve substantial risks and uncertainties that may cause actual results to differ materially from those that the Company expects. These risks and uncertainties include market risks, trends and conditions. These and other risks are more fully described in the Company’s filings with the Securities and Exchange Commission, including in the section titled “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 and Annual Report for the fiscal year ended September 30, 2022. In light of these risks, you should not place undue reliance on such forward-looking statements. Forward-looking statements represent the Company’s beliefs and assumptions only as of the date of this Current Report on Form 8-K. The Company disclaims any obligation to update forward-looking statements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Cerence Inc. | ||||||
Date: June 22, 2023 | By: | /s/ Thomas L. Beaudoin | ||||
Name: | Thomas L. Beaudoin | |||||
Title: | Executive Vice President and Chief Financial Officer |
Exhibit 99.1
Cerence Inc. Announces Proposed Offering of $190 Million Convertible Senior Notes due 2028
BURLINGTON, Mass., June 21, 2023Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today that it intends to offer, subject to market conditions and other factors, $190.0 million aggregate principal amount of convertible senior notes due 2028 (the notes) in a private offering (the offering) only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). In connection with the offering, Cerence expects to grant the initial purchasers an option to purchase up to an additional $20.0 million aggregate principal amount of notes.
The final terms of the notes, including the initial conversion rate, interest rate and certain other terms, will be determined at the time of pricing. The notes will bear interest semi-annually in arrears and will mature on July 1, 2028, unless earlier converted, redeemed or repurchased. Prior to April 3, 2028, the notes will be convertible only upon satisfaction of certain conditions and during certain periods. On or after April 3, 2028, the notes will be convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.
Cerence may not redeem the notes prior to July 6, 2026. On or after July 6, 2026 and on or before the 31st scheduled trading day immediately before the maturity date, Cerence may redeem for cash all or any portion of the notes (subject to certain limitations) if the last reported sale price of Cerences common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which Cerence provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Cerence provides notice of redemption. The redemption price will equal 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the notes.
The notes will be convertible at the option of holders, subject to certain conditions and during certain periods, into cash, shares of Cerences common stock or a combination of cash and shares of Cerences common stock, with the form of consideration determined at Cerences election. Holders of the notes will have the right to require Cerence to repurchase all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain events.
When issued, the notes will be Cerences senior unsecured obligations and will rank senior in right of payment to any of Cerences indebtedness that is expressly subordinated in right of payment to the notes; equal in right of payment to any of Cerences liabilities that are not so subordinated; effectively junior in right of payment to any of Cerences secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of Cerences subsidiaries.
Cerence intends to use a portion of the net proceeds from the offering to finance the concurrent repurchase of a portion of its 3.00% convertible senior notes due 2025 (the 2025 notes) as described below. Cerence intends to use the remaining net proceeds from the offering, together with borrowings under its revolving credit facility to the extent the initial purchasers do not exercise their option to purchase additional notes in full, to repay approximately $106.8 million under its term loan facility, which amount constitutes all of the borrowings and accrued and unpaid interest thereunder. Cerence intends to use the additional remaining net proceeds from the offering, if any, for general corporate purposes.
Contemporaneously with the pricing of the notes in the offering, Cerence expects to enter into individual privately negotiated transactions with certain holders of the 2025 notes, which will be effected through one of the initial purchasers or its affiliate acting as Cerences agent, to repurchase a portion of the 2025 notes on terms to be negotiated with each of such holders (each a note repurchase and collectively the 2025 notes repurchases). The terms of each note repurchase will depend on several factors, including the market price of Cerences common stock and the trading price of the 2025 notes at the time of each such note repurchase. No assurance can be given as to how much, if any, of the 2025 notes will be repurchased or the terms on which they will be repurchased.
Cerence expects that holders of 2025 notes who participate in the 2025 notes repurchases and who have hedged their equity price risk with respect to the 2025 notes may enter into or unwind various derivatives with respect to Cerences common stock and/or purchase shares of its common stock concurrently with or shortly after the pricing
of the notes. In addition, Cerence expects that certain purchasers of the notes offered in the offering may establish a short position with respect to its common stock by short selling the common stock or by entering into short derivative positions with respect to the common stock, in each case, in connection with the offering. The net effect of the above market activities by holders of 2025 notes and purchasers of the notes offered in the offering could increase (or reduce the size of any decrease in) or decrease (or reduce the size of any increase in) the market price of Cerences common stock, the market price of the notes offered in the offering or the 2025 notes and/or the initial conversion price of the notes, and Cerence cannot predict the magnitude of such market activities or the overall effect they will have on the market price of its common stock, the market price of the notes offered in the offering or the 2025 notes or the initial conversion price of the notes.
The notes will be offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The notes and the common stock, if any, issuable upon conversion of the notes are not being registered under the Securities Act, or the securities laws of any other jurisdiction. The notes and the common stock issuable upon conversion of the notes, if any, may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the Securities Act and any applicable state securities laws.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
About Cerence Inc.
Cerence is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the worlds leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, AI-powered interaction between humans and their vehicles, connecting consumers digital lives to their daily journeys no matter where they are. Cerences track record is built on more than 20 years of knowledge and 475 million cars shipped with Cerence technology. Whether its connected cars, autonomous driving, e-vehicles, or two-wheelers, Cerence is mapping the road ahead.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements relating to: whether Cerence will offer and issue the notes and the terms of the notes; the intended use of the net proceeds from the offering; the potential effects of the 2025 notes repurchases on Cerences common stock, the market price of the notes and the 2025 notes or the initial conversion price of the notes; and Cerences expectations in respect of granting the initial purchasers an option to purchase additional notes. Any statements that are not statements of historical fact (including statements containing the words believes, plans, anticipates, expects, intends or estimates or similar expressions) should also be considered to be forward-looking statements. Although Cerence believes the forward-looking statements included in this press release are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, which may cause actual results to be materially different from any future results expressed or implied by such forward-looking statements, including but not limited to: risks related to whether Cerence will consummate the offering of the notes on the expected terms, or at all, the anticipated principal amount of the notes, which could differ based upon market conditions, the actual use of the net proceeds from the offering, which could change from Cerences intended use of the net proceeds as a result of market conditions or for other reasons, prevailing market and other general economic, industry or political conditions in the United States or internationally, the impacts of the COVID-19 pandemic on our and our customers businesses, the impact of the war in Ukraine on our and our customers businesses and whether Cerence will be able to satisfy the conditions required to close any sale of the notes or the 2025 notes repurchases. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. For information about other potential factors that could affect Cerences business and financial results, please review the Risk Factors described in Cerences Annual Report on Form 10-K for the year ended September 30, 2022 and Cerences Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the Securities and Exchange Commission (the SEC) and in Cerences other filings with the SEC. Except as may be required by law, Cerence disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
Exhibit 99.2
Cerence Inc. Prices Offering of $190 Million 1.50% Convertible Senior Notes due 2028
BURLINGTON, Mass., June 22, 2023Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today the pricing of $190.0 million aggregate principal amount of 1.50% convertible senior notes due 2028 (the notes) in a private offering (the offering) only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). In connection with the offering, Cerence granted the initial purchasers an option to purchase up to an additional $20.0 million aggregate principal amount of notes. The sale of the notes to the initial purchasers is expected to close on June 26, 2023, subject to customary closing conditions.
The notes will bear interest at a rate of 1.50% per year, payable semi-annually in arrears on January 1 and July 1 of each year, beginning January 1, 2024. The notes will mature on July 1, 2028, unless earlier converted, redeemed or repurchased. Prior to April 3, 2028, the notes will be convertible only upon satisfaction of certain conditions and during certain periods. On or after April 3, 2028, the notes will be convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.
Cerence may not redeem the notes prior to July 6, 2026. On or after July 6, 2026 and on or before the 31st scheduled trading day immediately before the maturity date, Cerence may redeem for cash all or any portion of the notes (subject to certain limitations) if the last reported sale price of Cerences common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which Cerence provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Cerence provides notice of redemption. The redemption price will equal 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the notes.
The notes will be convertible at the option of holders, subject to certain conditions and during certain periods, into cash, shares of Cerences common stock or a combination of cash and shares of Cerences common stock, with the form of consideration determined at Cerences election. Holders of the notes will have the right to require Cerence to repurchase all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain events. The conversion rate will initially be 24.5586 shares of Cerences common stock per $1,000 principal amount of notes (which is equivalent to an initial conversion price of approximately $ $40.72 per share of Cerences common stock). The initial conversion price of the notes represents a premium of approximately 22.5% over the last reported sale price of Cerences common stock of $33.24 per share on June 21, 2023.
When issued, the notes will be Cerences senior unsecured obligations and will rank senior in right of payment to any of Cerences indebtedness that is expressly subordinated in right of payment to the notes; equal in right of payment to any of Cerences liabilities that are not so subordinated; effectively junior in right of payment to any of Cerences secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of Cerences subsidiaries.
Cerence estimates that the net proceeds from the offering of notes will be approximately $184.1 million (or approximately $203.6 million if the initial purchasers exercise their option to purchase additional notes in full), after deducting the initial purchasers discounts and estimated offering expenses payable by Cerence.
Cerence intends to use approximately $102.0 million of the net proceeds from the offering to finance the concurrent repurchase of a portion of its 3.00% convertible senior notes due 2025 (the 2025 notes) as described below. Cerence intends to use the remaining net proceeds from the offering, together with up to approximately $24.7 million that Cerence will borrow under its revolving credit facility to the extent the initial purchasers do not exercise their option to purchase additional notes in full, to repay approximately $106.8 million under its term loan facility, which amount constitutes all of the borrowings and accrued and unpaid interest thereunder. Cerence intends to use the additional remaining net proceeds from the offering, if any, for general corporate purposes.
Contemporaneously with the pricing of the notes in the offering, Cerence entered into individual privately negotiated transactions with certain holders of the 2025 notes, which were effected through one of the initial purchasers or its affiliate acting as Cerences agent, to repurchase $87.5 million in aggregate principal amount of the 2025 notes for approximately $102.0 million in cash (each a note repurchase and collectively the 2025 notes repurchases), which amount includes accrued and unpaid interest on the 2025 notes to be repurchased.
Cerence expects that holders of 2025 notes who agreed to participate in the 2025 notes repurchases and who have hedged their equity price risk with respect to the 2025 notes may enter into or unwind various derivatives with respect to Cerences common stock and/or purchase shares of its common stock concurrently with or shortly after the pricing of the notes. In addition, Cerence expects that certain purchasers of the notes offered in the offering may establish a short position with respect to its common stock by short selling the common stock or by entering into short derivative positions with respect to the common stock, in each case, in connection with the offering. The net effect of the above market activities by holders of 2025 notes and purchasers of the notes offered in the offering could increase (or reduce the size of any decrease in) or decrease (or reduce the size of any increase in) the market price of Cerences common stock and/or the market price of the notes offered in the offering or the 2025 notes and may have affected the initial conversion price of the notes, and Cerence cannot predict the magnitude of such market activities or the overall effect they will have on the market price of its common stock, the market price of the notes offered in the offering or the 2025 notes.
The notes will be sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The notes and the common stock, if any, issuable upon conversion of the notes are not being registered under the Securities Act, or the securities laws of any other jurisdiction. The notes and the common stock issuable upon conversion of the notes, if any, may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the Securities Act and any applicable state securities laws.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
About Cerence Inc.
Cerence is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the worlds leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, AI-powered interaction between humans and their vehicles, connecting consumers digital lives to their daily journeys no matter where they are. Cerences track record is built on more than 20 years of knowledge and 475 million cars shipped with Cerence technology. Whether its connected cars, autonomous driving, e-vehicles, or two-wheelers, Cerence is mapping the road ahead.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements relating to: the timing and closing of the offering of notes and the 2025 notes repurchases; the intended use of the net proceeds from the offering; and the potential effects of the 2025 notes repurchases on Cerences common stock and the market price of the notes and the 2025 notes. Any statements that are not statements of historical fact (including statements containing the words believes, plans, anticipates, expects, intends or estimates or similar expressions) should also be considered to be forward-looking statements. Although Cerence believes the forward-looking statements included in this press release are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, which may cause actual results to be materially different from any future results expressed or implied by such forward-looking statements, including but not limited to: risks related to whether Cerence will consummate the offering of the notes, the actual use of the net proceeds from the offering, which could change from Cerences intended use of the net proceeds as a result of market conditions or for other reasons, prevailing market and other general economic, industry or political conditions in the United States or internationally, the impacts of the COVID-19 pandemic on our and our customers businesses, the impact of the war in Ukraine on our and our customers businesses and whether Cerence will be able to satisfy the conditions required to close any sale of the notes or the 2025 notes repurchases. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. For information about other potential factors that could affect Cerences business and financial results, please review the Risk Factors described in Cerences Annual Report on Form 10-K for the year ended September 30, 2022 and Cerences Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the Securities and Exchange Commission (the SEC) and in Cerences other filings with the SEC. Except as may be required by law, Cerence disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.